Blood test kit
Latest Critical Care Diagnostics, Inc. Patents:
Description
The broken lines seen on the top of the blood test kit are included for the purpose of illustrating portions of the blood test kit that form no part of the claimed design. The broken lines seen on the bottom of the blood test kit are included for the purpose of illustrating a boundary of an unclaimed area of the blood test kit that forms no part of the claimed design.
Claims
The ornamental design for a blood test kit, as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
5728587 | March 17, 1998 | Kang |
5939331 | August 17, 1999 | Burd |
6239445 | May 29, 2001 | Shaeef |
6267722 | July 31, 2001 | Anderson |
D454398 | March 12, 2002 | Robertson |
D456082 | April 23, 2002 | Bouse |
D467348 | December 17, 2002 | McMichael |
D468437 | January 7, 2003 | McMenamy |
D495805 | September 7, 2004 | Lea |
D500142 | December 21, 2004 | Crisanti |
6855561 | February 15, 2005 | Jerome |
D512512 | December 6, 2005 | Bell |
D531321 | October 31, 2006 | Godfrey |
7285425 | October 23, 2007 | Shareef |
D561344 | February 5, 2008 | Kozak |
7326578 | February 5, 2008 | Bateman |
D602599 | October 20, 2009 | Xiaowei |
7847946 | December 7, 2010 | Krauth |
D639977 | June 14, 2011 | Francis |
D640389 | June 21, 2011 | Francis |
D655424 | March 6, 2012 | Castanon |
D660977 | May 29, 2012 | Wagner |
D660978 | May 29, 2012 | Wagner |
8268636 | September 18, 2012 | Nazareth |
D668350 | October 2, 2012 | Rowley |
D668779 | October 9, 2012 | Khan |
8278109 | October 2, 2012 | Nazareth |
D676570 | February 19, 2013 | Chance |
- Sanada, et al.; “IL-33 and ST2 Comprise a Critical Biomechanically Induced and Cardioprotective Signaling System”; The Journal of Clinical Investigation; May 10, 2007.
- Sanchez-Mas, et al.; “Modulcation of IL-33/ST2 System in Postinfraction Heart Failure: correlation with Cardiac Remodeling Markers”; European Journal of Clinical Investigation; vol. 44; 2014; pp. 643-651.
- Seki, et al.; “Interleukin-33 Prevents Apoptosis and Improves survival After Experimental Myocardial Infarction Through ST2 Signaling”; American Heart Association; Feb. 16, 2010.
Patent History
Patent number: D800332
Type: Grant
Filed: Sep 23, 2014
Date of Patent: Oct 17, 2017
Assignee: Critical Care Diagnostics, Inc. (San Diego, CA)
Inventors: James V. Snider (San Diego, CA), David Geliebter (Palm Beach Gardens, FL)
Primary Examiner: Ian Simmons
Assistant Examiner: Mark Cavanna
Application Number: 29/503,095
Type: Grant
Filed: Sep 23, 2014
Date of Patent: Oct 17, 2017
Assignee: Critical Care Diagnostics, Inc. (San Diego, CA)
Inventors: James V. Snider (San Diego, CA), David Geliebter (Palm Beach Gardens, FL)
Primary Examiner: Ian Simmons
Assistant Examiner: Mark Cavanna
Application Number: 29/503,095
Classifications
Current U.S. Class:
Interrelated Indication Or Reaction Set (i.e., "test Kit") (64) (D24/223)